Budget 2019 Must Address Some Immediate Needs in the Larger Interest of the Economy

Budget 2019 Must Address Some Immediate Needs in the Larger Interest of the Economy

The Budget that will be presented on February 1, 2019 will have to factor the forthcoming general elections and I therefore expect it to be populist in nature. The Agriculture, Healthcare and Education sectors are likely to receive priority attention. However, I do expect certain Industry sectors like the MSME and Start-ups to receive a [...]

2018 – A Year When Healthcare in India Got a Booster Shot

2018 – A Year When Healthcare in India Got a Booster Shot

2018 has been a happening year for healthcare in India. Developments such as the launch of the government’s flagship universal healthcare program, Ayushman Bharat; the insurance regulator's direction to insurers to cover mental illness; the heightened focus on public screening of non-communicable diseases, all  point to the fact that healthcare is starting to get the [...]

REALISING THE GAME CHANGING POTENTIAL OF NHPS

REALISING THE GAME CHANGING POTENTIAL OF NHPS

The NDA government’s announcement of a health insurance scheme covering 500 million poor and needy Indians is indeed laudable. An estimated 75 million Indians are driven to bankruptcy and poverty each year because they have to pay over 60% of hospitalisation costs out of their own pockets. Given the dismal healthcare scenario, the NHPS can [...]

An Inclusive Budget

An Inclusive Budget

By Kiran Mazumdar Shaw The Finance Minister has presented a comprehensive and wide-ranging Budget for FY19, which addresses most of the areas that need focus to ensure sustainable, long-term and equitable growth of the Indian economy. The Union Budget needed to be prudent and forward-looking rather than populist and that is exactly what Finance Minister [...]

A Journey of Endurance

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, [...]

Crusader for Affordable Healthcare

Crusader for Affordable Healthcare

Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of topics, including women as entrepreneurs, philanthropy, affordable healthcare, citizen activism etc. Here’s the full version of the interview. As a woman business leader, what are some of the challenges you have encountered in getting to the top and how were [...]

India To Be A Biotech Hot Spot

India To Be A Biotech Hot Spot

The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced [...]